Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Journal of the Neurological Sciences|April 12, 2020
Cytokine profile during pregnancy predicts relapses during pregnancy and postpartum in multiple sclerosisJuan Pablo Cuello, María Luisa Martínez Ginés, Amalia Tejeda-Velarde, et al.Clinical Immunology (Orlando, Fla.)|June 5, 2017
Multimarker risk stratification approach at multiple sclerosis onsetLidia Fernández-Paredes, Armanda Casrouge, Jérémie Decalf, et al.Scientific Reports|April 20, 2021
Evolution of antibody titres against Epstein-Barr virus and human herpesvirus 6A/B and expression of multiple sclerosis-associated retrovirus in the serum of pregnant multiple sclerosis patientsSilvia Pérez-Pérez, Juan Pablo Cuello, Marisa Martínez-Ginés, et al.Annals of Neurology|June 10, 2014
Immunoglobulin M oligoclonal bands: biomarker of targetable inflammation in primary progressive multiple sclerosisLuisa M Villar, Bonaventura Casanova, Nadia Ouamara, et al.Frontiers in Immunology|December 22, 2025
New serum soluble factors predicting inflammatory and non-inflammatory disability worsening in multiple sclerosisAlexander Rodero-Romero, María Domínguez-Mozo, Enric Monreal, et al.Frontiers in Immunology|August 25, 2025
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosisAlexander Rodero-Romero, José Ignacio Fernández-Velasco, Enric Monreal, et al.Frontiers in Immunology|July 29, 2021
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple SclerosisCarmen Picón, Amalia Tejeda-Velarde, José Ignacio Fernández-Velasco, et al.JAMA Neurology|February 27, 2023
Association of Serum Neurofilament Light Chain Levels at Disease Onset With Disability Worsening in Patients With a First Demyelinating Multiple Sclerosis Event Not Treated With High-Efficacy DrugsEnric Monreal, José Ignacio Fernández-Velasco, María Isabel García-Sánchez, et al.Brain : a Journal of Neurology|August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosisEnric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.Annals of Neurology|January 13, 2015
Lipid-specific immunoglobulin M bands in cerebrospinal fluid are associated with a reduced risk of developing progressive multifocal leukoencephalopathy during treatment with natalizumabLuisa M Villar, Lucienne Costa-Frossard, Thomas Masterman, et al.Pageof 6